Alison Kodjak
-
Certain high-cost drugs are straining state budgets. A new deal approved Wednesday allows Louisiana to spend a fixed amount for unlimited access to a costly cure. Other states may try to follow suit. -
A quirk in the law gives an older opioid addiction treatment "orphan drug" status — and a period of exclusive market access. That may prevent some new therapies from reaching patients for years. -
A federal judge has struck down a Medicaid work requirement in Arkansas and Kentucky. This is a major blow to the Trump administration's vision for the health insurance program for low-income people.
-
Justice Department files notice that it agrees with a federal judge's ruling that the ACA should be thrown out. The administration had previously said it wanted only parts of the law invalidated.
-
The Trump administration wants to increase transparency in prescription drug pricing. But health economists say the administration's call to tie prices to what other nations pay might work better. -
In a surprise move, the Food and Drug Administration commissioner announced Tuesday he will resign from his position. Dr. Scott Gottlieb is widely viewed as an effective advocate of public health.
-
The CEOs of seven U.S. drug makers testified before the Senate Finance Committee on their pricing practices.
-
Democratic Sen. Kamala Harris, who's a candidate for the 2020 presidential election, has endorsed "Medicare for all." But the details of what that means are rather elusive.
-
A federal judge in Texas issued a ruling Friday declaring the Affordable Care Act unconstitutional, apparently setting the stage for another hearing on the health care law by the U.S. Supreme Court.
-
A Texas judge on Friday said that the Affordable Care Act is unconstitutional — a ruling likely to be appealed and to make its way up to the Supreme Court.
